Scrip is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ipsen recruits new SVP from BMS

This article was originally published in Scrip

Executive Summary

Ipsen has appointed Dominique Laymand senior vice-president, chief ethics and compliance officer, effective 16 March. She will report to Marc de Garidel, Ipsen's chair and CEO. Ms Laymand most recently served as vice-president of compliance and ethics at Bristol-Myers Squibb, where she has been employed since 1983 in various roles. Ms Laymand is also president of ETHICS, an association that gathers international Ethics and Compliance experts in the Healthcare sector, and president of the compliance committee at both European industry association EFPIA and French industry association Leem.

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

SC027974

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel